About
Ulrik holds an MSc in Engineering, and a BSc in International Economics. Prior to joining Novo A/S, he spent seven years within international marketing, product- and business-development in the life science area and almost ten years in Novo Nordisk A/S; from 1994 as Director of Corporate Development responsible for M&A strategy and execution, equity investments etc. He then led Novo's venture activities at their initiation in 1999 and was Senior Partner until 2008, co-responsible for building the strong venture portfolio in its initial decade. In 2009 he stepped out of the venture team to initiate the Growth Equity efforts as Managing Partner, and recently he has been given responsibility for Novo A/S’s new investment focus towards established life science companies. Ulrik has extensive international experience serving on boards of venture funded companies through more than 15 years and he is currently a member of the Board of Directors of Archimedes Pharma Ltd and of the Danish Ven
Position in the VCSift Database
- • 8 investors at Vaekstfonden are tracked.
- • 1 investors hold the Advisor role in VCSift. Ulrik Spork is one of them.
- • 666 investors are based in Copenhagen, Hovedstaden, Denmark.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Copenhagen, Denmark
Contact Information
Find more investors like Ulrik
Search Investors